Su Hyun Seok

Dr. Su Hyun Seok

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SKSeongkyu Kim
Seongkyu Kim
JKJe-Hein Kim
Je-Hein Kim
SSSu Hyun Seok
Su Hyun Seok
EPEun-Seok Park
Eun-Seok Park

1 February 2018 in Powder Technology
Verified
Journal Article
Closed access
CCCheol-Hee Cho
Cheol-Hee Cho
KHKyu-Mok Hwang
Kyu-Mok Hwang
KHKyu-Min Hwang
Kyu-Min Hwang
SSSu Hyun Seok
Su Hyun Seok
SKSu-Hyeon Kim
Su-Hyeon Kim
EPEun-Seok Park
Eun-Seok Park

7 November 2022 in Toxics
Verified
Journal Article
Open access
PDF file
WJWoohyung Jung
Woohyung Jung
SSSu Hyun Seok
Su Hyun Seok
Soyoung ShinSoyoung Shin
Soyoung Shin
SRSung Ha Ryu
Sung Ha Ryu
KKKyu-Bong Kim
Kyu-Bong Kim
Tae Hwan KimTae Hwan Kim
Tae Hwan Kim
The aim of this study was to evaluate in vitro skin permeation and deposition, in vivo toxicokinetics, percutaneous absorption and tissue distribution of benzophenone-3 (BP-3) in rats. Four transdermal formulations containing BP-3 were prepared and evaluated for in vitro skin permeation and deposition of BP-3 using Franz diffusion cells. A gel formulation was used in subsequent in vivo percutaneous absorption due to its high in vitro skin permeation and deposition. Compared to intravenous (i.v.) injection, the prolonged terminal t1/2 (3.1 ± 1.6 h for i.v. injection and 18.3 ± 5.8 h for topical application) was observed indicating occurrence of flip-flop kinetics after topical application. The bioavailability of BP-3 after topical application was 6.9 ± 1.8%. The tissue-to-plasma partition coefficient (kp) for testis, considered a toxic target for BP-3, was less than 1. Overall, findings of this study may be useful for risk assessment of BP-3.

7 December 2022 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Closed access
PDF file
HPHye-Ryeong Park
Hye-Ryeong Park
SSSu Hyun Seok
Su Hyun Seok
EPEun-Seok Park
Eun-Seok Park